Article
Breakthrough invasive fungal infections: Who is at risk?
Mycoses - 1 Oct 2020
Jenks Jeffrey D, Cornely Oliver A, Chen Sharon C-A, Thompson George R, Hoenigl Martin
Abstract excerpt
The epidemiology of invasive fungal infections (IFIs) in immunocompromised individuals has changed over the last few decades, partially due to the increased use of antifungal agents to prevent IFIs. Although this strategy has resulted in an overall reduction in IFIs, a subset of patients develop breakthrough IFIs with substantial morbidity and mortality in this population. Here, we review the most significant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.